GENEVA, Oct. 1 -- UNIVERSITY OF OTTAWA filed a patent application (CA2026/050383) for “A MACHINE LEARNING PLATFORM AND METHOD FOR INTERCONNECTING ANTIBODY-DRUG CONJUGATE CYTOTOXIC DESIGN WITH TUMOR CELL BIOLOGY”. With publication no. WO/2026/188334, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: G16B 40/20
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....